𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin

✍ Scribed by Jean–Pierre Bronowicki; Denis Ouzan; Tarik Asselah; Hervé Desmorat; Jean–Pierre Zarski; Juliette Foucher; Marc Bourlière; Christophe Renou; Albert Tran; Pascal Melin; Christophe Hézode; Michelle Chevalier; Magali Bouvier–Alias; Stéphane Chevaliez; François Montestruc; Isabelle Lonjon–Domanec; Jean–Michel Pawlotsky

Book ID
119759409
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
378 KB
Volume
131
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to pegylated interferon alfa-2a
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4
✍ Hesham El Makhzangy; Gamal Esmat; Mohamed Said; Maissa ElRaziky; Soheir Shouman; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract The safety and efficacy of pegylated interferon (PEG‐IFN) alfa‐2a and ribavirin were studied among patients treated for genotype 4 chronic hepatitis C. Ninety‐five patients with chronic hepatitis C genotype 4 were treated with PEG‐IFN alfa‐2a (180 µg/week) plus ribavirin (≥11 mg/kg/day)